🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as 17-N-allylamino-17-demethoxy...
Status
Completed
Location
Jonsson Comprehensive Cancer Center at UCLA
Start Date
2004-10
Trial ID
NCT00100997
Treatments Being Tested
This phase I trial is studying the side effects and best dose of giving tan...
Status
Terminated
Location
Mayo Clinic
Start Date
2004-11
Trial ID
NCT00096005
Treatments Being Tested
This phase II trial is studying how well 17-AAG works in treating patients ...
Status
Completed
Location
Mayo Clinic
Start Date
2005-01
Trial ID
NCT00118092
Treatments Being Tested
This phase I trial is studying the side effects and best dose of sorafenib ...
Status
Completed
Location
Mayo Clinic
Start Date
2005-12
Trial ID
NCT00303797
Treatments Being Tested
This is a phase 1 clinical trial to find the safe, maximum tolerated dose o...
Status
Completed
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2005-06
Trial ID
NCT00113204
Treatments Being Tested
This study is a Phase I clinical trial of IPI-504 in combination with docet...
Status
Completed
Location
TGen Clinical Research in Scottsdale
Start Date
2007-12
Trial ID
NCT00606814
Treatments Being Tested
The purpose of this study is to evaluate the safety, determine the maximum ...
Status
Terminated
Location
Johns Hopkins Sidney Kimmel Cancer Center
Start Date
2010-06
Trial ID
NCT01193491
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Jonsson Comprehensive Cancer Center, UCLA
Start Date
1999-07
Trial ID
NCT00004065
Treatments Being Tested
This phase I trial is studying the side effects and best dose of 17-AAG whe...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2005-03
Trial ID
NCT00121264
To determine MTD and DLT of ABI-010 given weekly every three weeks followed...
Status
Withdrawn
Location
Mayo Clinic
Start Date
2012-04-01
Trial ID
NCT00820768
Treatments Being Tested